 | Oramed Pharmaceuticals Inc. | |||
| NCM : ORMP || Location: United States | ||||
$2.33+0.06 (+2.64%) |
0.06 M | 2.25 - 2.4 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| March 28, 2024 | 0.584 M |
| March 15, 2024 | 0.484 M |
| Feb. 29, 2024 | 0.501 M |
| Feb. 15, 2024 | 0.692 M |
| Jan. 31, 2024 | 0.393 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -0.12 | 0.33 | 369.61% |
| 09/30/2023 | -0.09 | -0.08 | 7.73% |
| 06/30/2023 | -0.10 | -0.03 | 70.59% |
| 03/31/2023 | -0.27 | -0.08 | 69.83% |
| 12/31/2022 | -0.23 | -0.22 | 5.42% |
ORMP Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 40.519M | Shares Float | 36.697M |
| Short Float | 0.584M | Market Cap | 94.41M |
| Institution ownership | 13.88% | Insider ownership | 11.230% |
| Earnings Date | 05/09/2024 BMO | Cash Per Share | ? |
| Trailing EPS | 0.14 | Forward EPS | -0.26 |